View Future GrowthINNOGENELtd 過去の業績過去 基準チェック /06INNOGENELtdの収益は年間平均-42.7%の割合で減少していますが、 Personal Products業界の収益は年間 増加しています。収益は年間20% 5.3%割合で 減少しています。 INNOGENELtdの自己資本利益率は1.1%であり、純利益率は1.6%です。主要情報-42.69%収益成長率-49.29%EPS成長率Personal Products 業界の成長3.77%収益成長率-5.34%株主資本利益率1.12%ネット・マージン1.62%前回の決算情報31 Mar 2026最近の業績更新更新なしすべての更新を表示Recent updatesお知らせ • Jul 28INNOGENE Co.,Ltd. announced that it has received KRW 3.36 billion in funding from Metamorphosis Co., Ltd and Jeong Gi-chul.On July 27, 2026, INNOGENE Co.,Ltd. has closed the transaction.New Risk • Jun 08New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₩15.2b (US$9.74m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 43% per year over the past 5 years. High level of non-cash earnings (23% accrual ratio). Market cap is less than US$10m (₩15.2b market cap, or US$9.74m). Minor Risk Profit margins are more than 30% lower than last year (1.6% net profit margin).New Risk • May 27New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 23% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 43% per year over the past 5 years. High level of non-cash earnings (23% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (1.6% net profit margin). Market cap is less than US$100m (₩18.0b market cap, or US$11.9m).Valuation Update With 7 Day Price Move • Mar 04Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to ₩1,334, the stock trades at a trailing P/E ratio of 69.9x. Average trailing P/E is 20x in the Personal Products industry in South Korea. Total loss to shareholders of 70% over the past three years.お知らせ • Feb 06INNOGENE Co.,Ltd., Annual General Meeting, Mar 26, 2026INNOGENE Co.,Ltd., Annual General Meeting, Mar 26, 2026, at 10:00 Tokyo Standard Time. Location: conference room, guro-gu, seoul South KoreaUpcoming Dividend • Dec 22Upcoming dividend of ₩80.00 per shareEligible shareholders must have bought the stock before 29 December 2025. Payment date: 13 April 2026. Trailing yield: 3.8%. Within top quartile of South Korean dividend payers (3.6%). Higher than average of industry peers (1.8%).New Risk • Dec 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 36% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.6% average weekly change). Profit margins are more than 30% lower than last year (2.9% net profit margin). Market cap is less than US$100m (₩27.1b market cap, or US$18.3m).お知らせ • Nov 12INNOGENE Co.,Ltd. announces Annual dividend, payable on April 13, 2026INNOGENE Co.,Ltd. announced Annual dividend of KRW 80.0000 per share payable on April 13, 2026, ex-date on December 29, 2025 and record date on December 31, 2025.New Risk • Aug 28New major risk - Revenue and earnings growthEarnings have declined by 31% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 31% per year over the past 5 years. Minor Risks Profit margins are more than 30% lower than last year (3.5% net profit margin). Market cap is less than US$100m (₩21.5b market cap, or US$15.5m).New Risk • May 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (₩31.1b market cap, or US$22.3m).New Risk • Jul 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (7.6% average weekly change). Market cap is less than US$100m (₩30.3b market cap, or US$22.0m).New Risk • Aug 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Shareholders have been diluted in the past year (15% increase in shares outstanding). Market cap is less than US$100m (₩48.2b market cap, or US$36.0m).お知らせ • Sep 07INNOGENE Co.,Ltd. has filed an IPO.INNOGENE Co.,Ltd. has filed an IPO. Security Name: Shares Security Type: Common Stock Price\Range: KRW 2500 to KRW 3000Is New 90 Day High Low • Feb 24New 90-day high: ₩1,200The company is up 19% from its price of ₩1,010 on 26 November 2020. The South Korean market is up 17% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is up 13% over the same period.お知らせ • Feb 10INNOGENE Co.,Ltd., Annual General Meeting, Mar 24, 2021INNOGENE Co.,Ltd., Annual General Meeting, Mar 24, 2021, at 10:00 Korea Standard Time.Is New 90 Day High Low • Jan 05New 90-day high: ₩1,175The company is up 7.0% from its price of ₩1,100 on 07 October 2020. The South Korean market is up 23% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 9.0% over the same period.収支内訳INNOGENELtd の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史KOSDAQ:A344860 収益、費用、利益 ( )KRW Millions日付収益収益G+A経費研究開発費31 Mar 269,0371465,85728131 Dec 258,2132885,69828030 Sep 257,8542295,33729030 Jun 257,6302675,10433231 Mar 258,6727555,29240731 Dec 248,9459455,30641430 Sep 2410,3181,2295,83344230 Jun 2410,5191,4755,65444031 Mar 2410,0361,4495,35042431 Dec 2310,1011,3965,39742930 Sep 238,9301,2044,69040530 Jun 239,1051,1934,87738631 Mar 239,3271,3414,88733931 Dec 229,1391,3394,73632731 Dec 219,3852,2584,38830931 Dec 195,644-4123,71942131 Dec 187,808694,589538質の高い収益: A344860 非現金収入 のレベルが高いです。利益率の向上: A344860の現在の純利益率 (1.6%)は、昨年(8.7%)よりも低くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: A344860の収益は過去 5 年間で年間42.7%減少しました。成長の加速: A344860は過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。収益対業界: A344860は過去 1 年間で収益成長率がマイナス ( -80.6% ) となったため、 Personal Products業界平均 ( 20.6% ) と比較することが困難です。株主資本利益率高いROE: A344860の 自己資本利益率 ( 1.1% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YHousehold 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/30 22:19終値2026/07/30 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋INNOGENE Co.,Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Jul 28INNOGENE Co.,Ltd. announced that it has received KRW 3.36 billion in funding from Metamorphosis Co., Ltd and Jeong Gi-chul.On July 27, 2026, INNOGENE Co.,Ltd. has closed the transaction.
New Risk • Jun 08New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₩15.2b (US$9.74m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 43% per year over the past 5 years. High level of non-cash earnings (23% accrual ratio). Market cap is less than US$10m (₩15.2b market cap, or US$9.74m). Minor Risk Profit margins are more than 30% lower than last year (1.6% net profit margin).
New Risk • May 27New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 23% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 43% per year over the past 5 years. High level of non-cash earnings (23% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (1.6% net profit margin). Market cap is less than US$100m (₩18.0b market cap, or US$11.9m).
Valuation Update With 7 Day Price Move • Mar 04Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to ₩1,334, the stock trades at a trailing P/E ratio of 69.9x. Average trailing P/E is 20x in the Personal Products industry in South Korea. Total loss to shareholders of 70% over the past three years.
お知らせ • Feb 06INNOGENE Co.,Ltd., Annual General Meeting, Mar 26, 2026INNOGENE Co.,Ltd., Annual General Meeting, Mar 26, 2026, at 10:00 Tokyo Standard Time. Location: conference room, guro-gu, seoul South Korea
Upcoming Dividend • Dec 22Upcoming dividend of ₩80.00 per shareEligible shareholders must have bought the stock before 29 December 2025. Payment date: 13 April 2026. Trailing yield: 3.8%. Within top quartile of South Korean dividend payers (3.6%). Higher than average of industry peers (1.8%).
New Risk • Dec 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 36% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.6% average weekly change). Profit margins are more than 30% lower than last year (2.9% net profit margin). Market cap is less than US$100m (₩27.1b market cap, or US$18.3m).
お知らせ • Nov 12INNOGENE Co.,Ltd. announces Annual dividend, payable on April 13, 2026INNOGENE Co.,Ltd. announced Annual dividend of KRW 80.0000 per share payable on April 13, 2026, ex-date on December 29, 2025 and record date on December 31, 2025.
New Risk • Aug 28New major risk - Revenue and earnings growthEarnings have declined by 31% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 31% per year over the past 5 years. Minor Risks Profit margins are more than 30% lower than last year (3.5% net profit margin). Market cap is less than US$100m (₩21.5b market cap, or US$15.5m).
New Risk • May 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (₩31.1b market cap, or US$22.3m).
New Risk • Jul 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (7.6% average weekly change). Market cap is less than US$100m (₩30.3b market cap, or US$22.0m).
New Risk • Aug 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Shareholders have been diluted in the past year (15% increase in shares outstanding). Market cap is less than US$100m (₩48.2b market cap, or US$36.0m).
お知らせ • Sep 07INNOGENE Co.,Ltd. has filed an IPO.INNOGENE Co.,Ltd. has filed an IPO. Security Name: Shares Security Type: Common Stock Price\Range: KRW 2500 to KRW 3000
Is New 90 Day High Low • Feb 24New 90-day high: ₩1,200The company is up 19% from its price of ₩1,010 on 26 November 2020. The South Korean market is up 17% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is up 13% over the same period.
お知らせ • Feb 10INNOGENE Co.,Ltd., Annual General Meeting, Mar 24, 2021INNOGENE Co.,Ltd., Annual General Meeting, Mar 24, 2021, at 10:00 Korea Standard Time.
Is New 90 Day High Low • Jan 05New 90-day high: ₩1,175The company is up 7.0% from its price of ₩1,100 on 07 October 2020. The South Korean market is up 23% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 9.0% over the same period.